Alzheimer’s disease is a neurodegenerative disorder that is characterized by the accumulation of beta-amyloid plaques and neurofibrillary tangles in the brain. While the exact causes of Alzheimer’s disease are not yet fully understood, there is evidence to suggest that oxidative stress and inflammation may play a role in the development of the disease.

Nicotinamide mononucleotide (NMN) is a molecule that has been shown to have anti-inflammatory and antioxidant properties, and some researchers have suggested that it may have potential benefits for Alzheimer’s disease.

While there is limited research on the use of NMN specifically for Alzheimer’s disease, there have been some studies that suggest it may have potential benefits for cognitive function. For example, a study published in the journal Aging Cell in 2019 found that NMN supplementation improved muscle strength and physical performance in healthy older adults, which may have implications for cognitive function.

Another study published in the journal Cell Reports in 2021 investigated the effects of NMN supplementation on cognitive function in mice. The study found that NMN supplementation improved cognitive function and reduced brain inflammation in the mice, suggesting that it may have potential benefits for brain health.

While these studies are promising, more research is needed to fully understand the potential benefits of NMN for Alzheimer’s disease. It is also worth noting that Alzheimer’s disease is a complex condition with many factors that contribute to its development and progression, and there is no single treatment or cure. If you or a loved one is experiencing symptoms of Alzheimer’s disease, it is important to talk to a healthcare provider for guidance on appropriate treatment options.